Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James M Cook

Showing results (211-220 of 329) with videos related to

Pageof 33
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 30, 2007
Are GABAA receptors containing alpha5 subunits contributing to the sedative properties of benzodiazepine site agonists?Miroslav M Savić, Shengming Huang, Roman Furtmüller, et al.
Journal of Alzheimer'S Disease : JAD|October 18, 2021
Positive and Negative Selective Allosteric Modulators of α5 GABAA Receptors: Effects on Emotionality, Motivation, and Motor Function in the 5xFAD Model of Alzheimer's DiseaseJovana Aranđelović, Anja Santrač, Bojan Batinić, et al.
Neuropharmacology|October 27, 2009
Discriminative stimulus effects of L-838,417 (7-tert-butyl-3-(2,5-difluoro-phenyl)-6-(2-methyl-2H-[1,2,4]triazol-3-ylmethoxy)-[1,2,4]triazolo[4,3-b]pyridazine): role of GABA(A) receptor subtypesStephanie C Licata, Donna M Platt, Daniela Rüedi-Bettschen, et al.
Journal of Psychopharmacology (Oxford, England)|November 1, 2019
Evaluation of the anti-conflict, reinforcing, and sedative effects of YT-III-31, a ligand functionally selective for α3 subunit-containing GABA<sub>A</sub> receptorsZhiqiang Meng, Lais F Berro, Eileen K Sawyer, et al.
Infection and Drug Resistance|September 15, 2012
Development of ceftazidime resistance in an acute Burkholderia pseudomallei infectionDerek S Sarovich, Erin P Price, Direk Limmathurotsakul, et al.
Biological Psychiatry Global Open Science|January 30, 2023
Hippocampal α5-GABA<sub>A</sub> Receptors Modulate Dopamine Neuron Activity in the Rat Ventral Tegmental AreaStephanie M Perez, Alexandra M McCoy, Thomas D Prevot, et al.
Frontiers in Pharmacology|October 18, 2023
Therapeutic effects of KRM-II-81, positive allosteric modulator for α2/3 subunit containing GABA<sub>A</sub> receptors, in a mouse model of Dravet syndromeSachiko Nakakubo, Yasuyoshi Hiramatsu, Takeru Goto, et al.
British Journal of Pharmacology|March 12, 2013
Identification of novel positive allosteric modulators and null modulators at the GABAA receptor α+β- interfaceZdravko Varagic, Laurin Wimmer, Michael Schnürch, et al.
Bioorganic & Medicinal Chemistry|June 12, 2010
A new class of potential anti-tuberculosis agents: Synthesis and preliminary evaluation of novel acrylic acid ethyl ester derivativesM Shahjahan Kabir, Ojas A Namjoshi, Ranjit Verma, et al.
Blood|August 19, 2006
ABCG2 expression, function, and promoter methylation in human multiple myelomaJoel G Turner, Jana L Gump, Chunchun Zhang, et al.
Pageof 33

Showing results (211-220 of 329) with videos related to

Sort By:
Pageof 33
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 30, 2007
Are GABAA receptors containing alpha5 subunits contributing to the sedative properties of benzodiazepine site agonists?Miroslav M Savić, Shengming Huang, Roman Furtmüller, et al.
Journal of Alzheimer'S Disease : JAD|October 18, 2021
Positive and Negative Selective Allosteric Modulators of α5 GABAA Receptors: Effects on Emotionality, Motivation, and Motor Function in the 5xFAD Model of Alzheimer's DiseaseJovana Aranđelović, Anja Santrač, Bojan Batinić, et al.
Neuropharmacology|October 27, 2009
Discriminative stimulus effects of L-838,417 (7-tert-butyl-3-(2,5-difluoro-phenyl)-6-(2-methyl-2H-[1,2,4]triazol-3-ylmethoxy)-[1,2,4]triazolo[4,3-b]pyridazine): role of GABA(A) receptor subtypesStephanie C Licata, Donna M Platt, Daniela Rüedi-Bettschen, et al.
Journal of Psychopharmacology (Oxford, England)|November 1, 2019
Evaluation of the anti-conflict, reinforcing, and sedative effects of YT-III-31, a ligand functionally selective for α3 subunit-containing GABA<sub>A</sub> receptorsZhiqiang Meng, Lais F Berro, Eileen K Sawyer, et al.
Infection and Drug Resistance|September 15, 2012
Development of ceftazidime resistance in an acute Burkholderia pseudomallei infectionDerek S Sarovich, Erin P Price, Direk Limmathurotsakul, et al.
Biological Psychiatry Global Open Science|January 30, 2023
Hippocampal α5-GABA<sub>A</sub> Receptors Modulate Dopamine Neuron Activity in the Rat Ventral Tegmental AreaStephanie M Perez, Alexandra M McCoy, Thomas D Prevot, et al.
Frontiers in Pharmacology|October 18, 2023
Therapeutic effects of KRM-II-81, positive allosteric modulator for α2/3 subunit containing GABA<sub>A</sub> receptors, in a mouse model of Dravet syndromeSachiko Nakakubo, Yasuyoshi Hiramatsu, Takeru Goto, et al.
British Journal of Pharmacology|March 12, 2013
Identification of novel positive allosteric modulators and null modulators at the GABAA receptor α+β- interfaceZdravko Varagic, Laurin Wimmer, Michael Schnürch, et al.
Bioorganic & Medicinal Chemistry|June 12, 2010
A new class of potential anti-tuberculosis agents: Synthesis and preliminary evaluation of novel acrylic acid ethyl ester derivativesM Shahjahan Kabir, Ojas A Namjoshi, Ranjit Verma, et al.
Blood|August 19, 2006
ABCG2 expression, function, and promoter methylation in human multiple myelomaJoel G Turner, Jana L Gump, Chunchun Zhang, et al.
Pageof 33